These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29672811)

  • 21. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
    Platzek I
    PET Clin; 2016 Oct; 11(4):363-73. PubMed ID: 27593243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inflammatory rheumatic diseases: MRI].
    Garlaschi G; Parodi S; Lacelli F; Silvestri E
    Reumatismo; 2006; 58 Spec No.1():78-9. PubMed ID: 23631069
    [No Abstract]   [Full Text] [Related]  

  • 24. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
    Rakheja R; Chandarana H; Ponzo F; Seltzer AL; Beltran LS; Geppert C; Friedman KP
    PET Clin; 2014 Apr; 9(2):237-52. PubMed ID: 25030285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Imaging in rheumatology].
    Backhaus M; Sandrock D; Schmidt WA
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1897-903. PubMed ID: 12235554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound versus low-field magnetic resonance imaging in rheumatic diseases: a systematic literature review.
    Aleo E; Barbieri F; Sconfienza L; Zampogna G; Garlaschi G; Cimmino MA
    Clin Exp Rheumatol; 2014; 32(1 Suppl 80):S91-8. PubMed ID: 24528870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Status of Hybrid PET/MRI in Oncologic Imaging.
    Rosenkrantz AB; Friedman K; Chandarana H; Melsaether A; Moy L; Ding YS; Jhaveri K; Beltran L; Jain R
    AJR Am J Roentgenol; 2016 Jan; 206(1):162-72. PubMed ID: 26491894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
    Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
    J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
    J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of magnetic resonance tomography (MRT) in inflammatory rheumatic diseases].
    Reiser M; Schneider M; Sittek H; Bongartz G
    Z Rheumatol; 1990; 49(2):61-9. PubMed ID: 2190435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of conventional radiography and scintigraphy in the third millennium.
    De Leonardis F; Orzincolo C; Prandini N; Trotta F
    Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):961-79. PubMed ID: 19041072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.